Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.
BJOG
; 114(6): 769, e1-12, 2007 Jun.
Article
em En
| MEDLINE
| ID: mdl-17516971
ABSTRACT
OBJECTIVE:
To compare the impact of 1000-microgram self-administered vaginal misoprostol versus self-administered vaginal placebo at home on preoperative cervical ripening in both premenopausal and postmenopausal women prior to outpatient resectoscopy.DESIGN:
Randomised, double-blind, placebo-controlled sequential trial.SETTING:
Norwegian university teaching hospital. SAMPLE Premenopausal and postmenopausal women referred to outpatient resectoscopy.METHODS:
The women were randomised to either 1000 micrograms of self-administered vaginal misoprostol or self-administered vaginal placebo the evening before outpatient resectoscopy. MAIN OUTCOMEMEASURES:
Preoperative cervical dilatation, acceptability and complications.RESULTS:
(a) Intraoperative findings and distribution of cervical dilatation in the two treatment groups. Values are given as median (range) or n (%). (b) Acceptability in the two treatment groups. Values are given as completely acceptable, n (%); fairly acceptable, n (%); fairly unacceptable, n (%) and completely unacceptable, n (%). (c) Pain in the two treatment groups. Pain was measured with a visual analogue scale score, scale ranges from 0 (no pain) to 10 (unbearable pain). Values are given as median (range). (d) Occurrence of adverse effects in the two treatment groups. Values are given as n (%). (e) Complications, given as n (%).
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ocitócicos
/
Complicações Pós-Operatórias
/
Doenças Uterinas
/
Histeroscopia
/
Misoprostol
/
Maturidade Cervical
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article